Skip to main content

Table 4 Univariate analysis for breast cancer-specific overall survival

From: Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing

Prognostic factor

P

RR

95% CI

Age

n.s.

-

-

Menopausal status

n.s.

-

-

pT stage

n.s.

-

-

Grade

0.0003

4.26

1.96–9.29

Steroid hormone receptor status

0.012

0.32

0.13–0.78

HER2_SCO

0.047

1.60

1.01–2.53

HER2_AMP

0.004

3.78

1.54–9.26

HER2_ALG

n.s.

-

-

HER2_COM

0.004

4.18

1.60–10.90

  1. CI, confidence interval; n.s., not significant; RR, relative risk.